Discounted Cash Flow
Healthstream Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $226.0m | $3.8m | $19.1m | 1.7% | $0.12 |
| 2017 | $247.7m (9.6%) | $10.0m (166.4%) | $40.7m (112.5%) | 4.0% (143.1%) | $0.31 (158.3%) |
| 2018 | $231.6m (-6.5%) | $32.2m (222.0%) | $36.1m (-11.3%) | 13.9% (244.4%) | $1.00 (222.6%) |
| 2019 | $254.1m (9.7%) | $15.8m (-51.1%) | $43.7m (21.0%) | 6.2% (-55.4%) | $0.49 (-51.0%) |
| 2020 | $244.8m (-3.7%) | $14.1m (-10.6%) | $33.9m (-22.4%) | 5.8% (-7.3%) | $0.44 (-10.2%) |
| 2021 | $256.7m (4.9%) | $5.8m (-58.5%) | $39.0m (15.0%) | 2.3% (-60.4%) | $0.19 (-56.8%) |
| 2022 | $266.8m (3.9%) | $12.1m (106.9%) | $49.4m (26.8%) | 4.5% (99.0%) | $0.39 (105.3%) |
| 2023 | $279.1m (4.6%) | $15.2m (25.8%) | $61.8m (25.0%) | 5.5% (20.3%) | $0.50 (28.2%) |
| 2024 | $291.6m (4.5%) | $20.0m (31.5%) | $56.3m (-8.9%) | 6.9% (25.8%) | $0.66 (32.0%) |
| 2025 | $304.1m (4.3%) | $18.3m (-8.3%) | $59.6m (6.0%) | 6.0% (-12.1%) | $0.61 (-7.6%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.